Cargando…
Population seroprevalence of antibody to influenza A(H7N9) virus, Guangzhou, China
BACKGROUND: Since the identification in early 2013 of severe disease caused by influenza A(H7N9) virus infection, there have been few attempts to characterize the full severity profile of human infections. Our objective was to estimate the number and severity of H7N9 infections in Guangzhou, using a...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5097368/ https://www.ncbi.nlm.nih.gov/pubmed/27814756 http://dx.doi.org/10.1186/s12879-016-1983-3 |
_version_ | 1782465586243043328 |
---|---|
author | Lin, Yong Ping Yang, Zi Feng Liang, Ying Li, Zheng Tu Bond, Helen S. Chua, Huiying Luo, Ya Sha Chen, Yuan Chen, Ting Ting Guan, Wen Da Lai, Jimmy Chun Cheong Siu, Yu Lam Pan, Si Hua Peiris, J. S. Malik Cowling, Benjamin J. PunMok, Chris Ka |
author_facet | Lin, Yong Ping Yang, Zi Feng Liang, Ying Li, Zheng Tu Bond, Helen S. Chua, Huiying Luo, Ya Sha Chen, Yuan Chen, Ting Ting Guan, Wen Da Lai, Jimmy Chun Cheong Siu, Yu Lam Pan, Si Hua Peiris, J. S. Malik Cowling, Benjamin J. PunMok, Chris Ka |
author_sort | Lin, Yong Ping |
collection | PubMed |
description | BACKGROUND: Since the identification in early 2013 of severe disease caused by influenza A(H7N9) virus infection, there have been few attempts to characterize the full severity profile of human infections. Our objective was to estimate the number and severity of H7N9 infections in Guangzhou, using a serological study. METHODS: We collected residual sera from patients of all ages admitted to a hospital in the city of Guangzhou in southern China in 2013 and 2014. We screened the sera using a haemagglutination inhibition assay against a pseudovirus containing the H7 and N9 of A/Anhui/1/2013(H7N9), and samples with a screening titer ≥10 were further tested by standard hemagglutination-inhibition and virus neutralization assays for influenza A(H7N9). We used a statistical model to interpret the information on antibody titers in the residual sera, assuming that the residual sera provided a representative picture of A(H7N9) infections in the general population, accounting for potential cross-reactions. RESULTS: We collected a total of 5360 residual sera from December 2013 to April 2014 and from October 2014 to December 2014, and found two specimens that tested positive for H7N9 antibody at haemagglutination inhibition titer ≥40 and a neutralization titer ≥40. Based on this, we estimated that 64,000 (95 % credibility interval: 7300, 190,000) human infections with influenza A(H7N9) virus occurred in Guangzhou in early 2014, with an infection-fatality risk of 3.6 deaths (95 % credibility interval: 0.47, 15) per 10,000 infections. CONCLUSIONS: Our study suggested that the number of influenza A(H7N9) virus infections in Guangzhou substantially exceeded the number of laboratory-confirmed cases there, albeit with considerable imprecision. Our study was limited by the small number of positive specimens identified, and larger serologic studies would be valuable. Our analytic framework would be useful if larger serologic studies are done. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-016-1983-3) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5097368 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-50973682016-11-07 Population seroprevalence of antibody to influenza A(H7N9) virus, Guangzhou, China Lin, Yong Ping Yang, Zi Feng Liang, Ying Li, Zheng Tu Bond, Helen S. Chua, Huiying Luo, Ya Sha Chen, Yuan Chen, Ting Ting Guan, Wen Da Lai, Jimmy Chun Cheong Siu, Yu Lam Pan, Si Hua Peiris, J. S. Malik Cowling, Benjamin J. PunMok, Chris Ka BMC Infect Dis Research Article BACKGROUND: Since the identification in early 2013 of severe disease caused by influenza A(H7N9) virus infection, there have been few attempts to characterize the full severity profile of human infections. Our objective was to estimate the number and severity of H7N9 infections in Guangzhou, using a serological study. METHODS: We collected residual sera from patients of all ages admitted to a hospital in the city of Guangzhou in southern China in 2013 and 2014. We screened the sera using a haemagglutination inhibition assay against a pseudovirus containing the H7 and N9 of A/Anhui/1/2013(H7N9), and samples with a screening titer ≥10 were further tested by standard hemagglutination-inhibition and virus neutralization assays for influenza A(H7N9). We used a statistical model to interpret the information on antibody titers in the residual sera, assuming that the residual sera provided a representative picture of A(H7N9) infections in the general population, accounting for potential cross-reactions. RESULTS: We collected a total of 5360 residual sera from December 2013 to April 2014 and from October 2014 to December 2014, and found two specimens that tested positive for H7N9 antibody at haemagglutination inhibition titer ≥40 and a neutralization titer ≥40. Based on this, we estimated that 64,000 (95 % credibility interval: 7300, 190,000) human infections with influenza A(H7N9) virus occurred in Guangzhou in early 2014, with an infection-fatality risk of 3.6 deaths (95 % credibility interval: 0.47, 15) per 10,000 infections. CONCLUSIONS: Our study suggested that the number of influenza A(H7N9) virus infections in Guangzhou substantially exceeded the number of laboratory-confirmed cases there, albeit with considerable imprecision. Our study was limited by the small number of positive specimens identified, and larger serologic studies would be valuable. Our analytic framework would be useful if larger serologic studies are done. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12879-016-1983-3) contains supplementary material, which is available to authorized users. BioMed Central 2016-11-04 /pmc/articles/PMC5097368/ /pubmed/27814756 http://dx.doi.org/10.1186/s12879-016-1983-3 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Lin, Yong Ping Yang, Zi Feng Liang, Ying Li, Zheng Tu Bond, Helen S. Chua, Huiying Luo, Ya Sha Chen, Yuan Chen, Ting Ting Guan, Wen Da Lai, Jimmy Chun Cheong Siu, Yu Lam Pan, Si Hua Peiris, J. S. Malik Cowling, Benjamin J. PunMok, Chris Ka Population seroprevalence of antibody to influenza A(H7N9) virus, Guangzhou, China |
title | Population seroprevalence of antibody to influenza A(H7N9) virus, Guangzhou, China |
title_full | Population seroprevalence of antibody to influenza A(H7N9) virus, Guangzhou, China |
title_fullStr | Population seroprevalence of antibody to influenza A(H7N9) virus, Guangzhou, China |
title_full_unstemmed | Population seroprevalence of antibody to influenza A(H7N9) virus, Guangzhou, China |
title_short | Population seroprevalence of antibody to influenza A(H7N9) virus, Guangzhou, China |
title_sort | population seroprevalence of antibody to influenza a(h7n9) virus, guangzhou, china |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5097368/ https://www.ncbi.nlm.nih.gov/pubmed/27814756 http://dx.doi.org/10.1186/s12879-016-1983-3 |
work_keys_str_mv | AT linyongping populationseroprevalenceofantibodytoinfluenzaah7n9virusguangzhouchina AT yangzifeng populationseroprevalenceofantibodytoinfluenzaah7n9virusguangzhouchina AT liangying populationseroprevalenceofantibodytoinfluenzaah7n9virusguangzhouchina AT lizhengtu populationseroprevalenceofantibodytoinfluenzaah7n9virusguangzhouchina AT bondhelens populationseroprevalenceofantibodytoinfluenzaah7n9virusguangzhouchina AT chuahuiying populationseroprevalenceofantibodytoinfluenzaah7n9virusguangzhouchina AT luoyasha populationseroprevalenceofantibodytoinfluenzaah7n9virusguangzhouchina AT chenyuan populationseroprevalenceofantibodytoinfluenzaah7n9virusguangzhouchina AT chentingting populationseroprevalenceofantibodytoinfluenzaah7n9virusguangzhouchina AT guanwenda populationseroprevalenceofantibodytoinfluenzaah7n9virusguangzhouchina AT laijimmychuncheong populationseroprevalenceofantibodytoinfluenzaah7n9virusguangzhouchina AT siuyulam populationseroprevalenceofantibodytoinfluenzaah7n9virusguangzhouchina AT pansihua populationseroprevalenceofantibodytoinfluenzaah7n9virusguangzhouchina AT peirisjsmalik populationseroprevalenceofantibodytoinfluenzaah7n9virusguangzhouchina AT cowlingbenjaminj populationseroprevalenceofantibodytoinfluenzaah7n9virusguangzhouchina AT punmokchriska populationseroprevalenceofantibodytoinfluenzaah7n9virusguangzhouchina |